LEXICON PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS - May 10, 2010

Attached files

file filename
10-Q - FORM 10-Q - LEXICON PHARMACEUTICALS, INC.form10-q_march302010.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - LEXICON PHARMACEUTICALS, INC.exh31_1.htm
EX-10.1 - COLLABORATION AND LICENSE AGREEMENT - LEXICON PHARMACEUTICALS, INC.exh10_1.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - LEXICON PHARMACEUTICALS, INC.exh31_2.htm


Exhibit 32.1
 
CERTIFICATION
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350, as adopted), Arthur T. Sands, M.D., Ph.D., Principal Executive Officer of Lexicon Pharmaceuticals, Inc. (“Lexicon”), and James F. Tessmer, Principal Financial Officer of Lexicon, each hereby certify that:
 
 
1.
Lexicon’s Quarterly Report on Form 10-Q for the period ended March 31, 2010, and to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934, and
 
 
2.
The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Lexicon.
 
IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 7th day of May, 2010.
 

By:
/s/ Arthur T. Sands
 
Arthur T. Sands, M.D., Ph.D.
 
President and Chief Executive Officer


By:
/s/ James F. Tessmer
 
James F. Tessmer
 
Vice President, Finance and Accounting


LEXICON PHARMACEUTICALS, INC. Reports

Also read